Literature DB >> 6451066

In vitro effects of cyclosporin A on lymphocyte subpopulations. 1. Suppressor cell sparing by cyclosporin A.

S B Leapman, R S Filo, E J Smith, P G Smith.   

Abstract

The fungal metabolite, cyclosporin A, is a potent immunosuppressive compound. Experiments were performed in vitro with both human and nonhuman primate peripheral blood lymphocytes to study the effect of this agent on suppressor cell activity. Cyclosporin A did not affect the generation or function of concanavalin A-induced suppressor lymphocytes as measured by their ability to suppress thymidine uptake of lymphocytes in secondary cultures. No evidence of suppressor cell induction was noted by incubation of lymphocytes with only cyclosporin A. We conclude that, although cyclosporin A does not generate or induce suppressor cell lymphocytes, it does spare them, while inhibiting other subpopulations. This effect may create an imbalance in the immune system which results in profound suppression.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6451066     DOI: 10.1097/00007890-198012000-00003

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  9 in total

1.  Human immune responses in vivo to protein (KLH) and polysaccharide (DNP-Ficoll) neoantigens: normal subjects compared with bone marrow transplant patients on cyclosporine.

Authors:  P L Amlot; A E Hayes; D Gray; E C Gordon-Smith; J H Humphrey
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

Review 2.  The influence of cyclosporin A on cell-mediated immunity.

Authors:  A W Thomson; L M Webster
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

3.  Cyclosporine in the treatment of steroid resistant rejection episodes in living donor kidney transplants.

Authors:  M Sobh; F el-Husseini; A Shebab el-Din; M Ghoneim
Journal:  Int Urol Nephrol       Date:  1987       Impact factor: 2.370

4.  Prevention of diabetes mellitus in the BB/W rat with Cyclosporin-A.

Authors:  A A Like; V Dirodi; S Thomas; D L Guberski; A A Rossini
Journal:  Am J Pathol       Date:  1984-10       Impact factor: 4.307

5.  Herpes simplex virus infection and damage in the central nervous system: immunomodulation with adjuvant, cyclophosphamide and cyclosporin A.

Authors:  S A Bishop; T J Hill
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

6.  The effect of cyclosporin A on the adoptive transfer of experimental allergic encephalomyelitis in the Lewis rat.

Authors:  C Bolton; G Allsopp; M L Cuzner
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

7.  Cyclosporin A: a new advance in transplantation.

Authors:  B D Kahan
Journal:  Tex Heart Inst J       Date:  1982-09

8.  Cyclosporin A: a powerful immunosuppressant.

Authors:  A Laupacis; P A Keown; R A Ulan; N McKenzie; C R Stiller
Journal:  Can Med Assoc J       Date:  1982-05-01       Impact factor: 8.262

9.  Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cells.

Authors:  B M Hall; M E Jelbart; K E Gurley; S E Dorsch
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.